Hambrecht & Quist Capital Management »

Vaxcyte shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $9.7M 194k 49.94
2023-03-31 $187k 5.0k 37.48
2022-12-31 $240k 5.0k 47.95

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Vaxcyte

FMR
Vanguard Group
Henderson Group
BlackRock
RA Capital Management
Capital Research Global Investors
Wellington Management Company
T. Rowe Price Associates
T. Rowe Price Investment Management
State Street Corporation
Franklin Resources
Geode Capital Management
Darwin Global Management
Perceptive Advisors
Westfield Capital Management Company

View all funds holding Vaxcyte